三鑫化工核心竞争力研究-工商管理专业论文.docxVIP

摘要 低价竞争是中国化学原料药出口企业的主要武器，但价格战不仅降低了产业 的利润，而且严重威胁着企业的生存和发展。三鑫化工作为中国抗高血压药血管 紧张素 II 受体拮抗剂原料药主要的生产和出口企业，不得不思考如何才能避开国 内竞争对手的价格战，持续保持在抗高血压原料药细分市场的竞争优势。 首先，本文基于核心竞争力理论的研究，分析并提升三鑫化工难以被竞争对 手所模仿和替代的核心竞争力。既然核心竞争力的特点是产业同行难以效仿，研 究核心竞争力就可以让企业轻易摆脱对手的价格战，在长期经营中获得别人不能 得到的竞争优势从而处于产业的领先地位。 其次，在前期对三鑫化工和全球降高血压化学原料药产业进行资料收集并对 行业资深人士进行访谈的基础上，综合分析公司现有的竞争能力，找出自己独特 的核心竞争力，再进一步分析和完善核心竞争力，保持我们在细分市场长期可持 续性的竞争优势。 最后，针对这些竞争能力的缺点提出完善的措施。在公司战略指导下，升级 企业核心竞争力，避开价格战从而提高企业的绩效。提出的措施有：一方面，用 加强型战略指导企业完善自己核心竞争力的劣势，选择市场渗透、市场开发和产品 开发作为增强公司在细分市场竞争优势的重点；另一方面，完善作为核心竞争力 基础的战略、组织结构、人力资源、企业文化和市场营销等竞争能力的缺陷，创建 学习型组织，让企业核心竞争力具备持续升级的机制去满足不断变化的客户需求， 从而摆脱价格战的困扰，保持在抗高血压原料药领域的持续盈利能力。 关键词：核心竞争力，化学原料药，血管紧张素 II 受体拮抗剂  ABSTRACT The competition relying on low price is the major weapon of Chinese pharmaceutical exporters,but price war not only cuts down industry’s profit but also threatens heavily companies’s survival and development.Sanxin Chemical Co.Ltd.has to consider how to upgrade the competence so that we avoid competitor’s the price war and keep our continuous advantage in the Anti-hypertensive market,as a major manufacturer and exporter of Angiotensin II receptor blocker in China. Firstly,basing on the core competence of the theory,this paper analyzes and lifts Sanxin Co.Ltd.’s core competence which is unique and difficult to be imitated by the competitors.Because the core competence’s feature is difficult to be imitated by the competitors,the analysis on that can help companies avoid price war,keep it competitive advantage in a long period and play a leading role in this industry. Secondly,relying on data collection from Sanxin Chemical Co.Ltd.the market of Anti-hypertensive and interviews with seniors in this industry,the paper theoretically and practically analyzes Sanxin Company’s basic competence then find its special core competence,and improves its disadvantage in order to continue to play a leading role in this market. Thirdly,formulating measures to improve these disadvantage.For avoiding price war and enhanc